Position in BMY
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$4,038,470
-$157,660 QoQ
Shares Held
70,088
+1.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
#606
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BENEDICT FINANCIAL ADVISORS INC holds $49,408,945 across 8 Drug Manufacturers - General names. BMY ranks #4 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
60,991 | $15,489,884 | |
| 2 | AMGN |
Amgen Inc
|
33,255 | $12,042,300 | |
| 3 | ABBV |
AbbVie Inc.
|
47,038 | $11,836,642 | |
| 4 | BMY |
Bristol Myers Squibb Co
This page
|
70,088 | $4,038,470 | |
| 5 | NVS |
Novartis AG
|
17,055 | $2,672,859 | |
| 6 | NVO |
Novo Nordisk A S
|
33,754 | $1,618,166 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
11,812 | $1,492,328 | |
| 8 | LLY |
ELI LILLY & Co
|
182 | $218,296 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,038,470 | 70,088 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $4,196,130 | 69,186 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $3,702,279 | 68,637 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $2,922,480 | 64,800 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $3,081,849 | 66,577 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,059,921 | 66,567 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $3,739,916 | 66,123 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $3,378,932 | 65,306 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $2,987,502 | 71,936 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $4,082,488 | 75,281 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $3,786,524 | 73,797 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $4,291,419 | 73,939 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $4,642,450 | 72,595 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $4,930,297 | 71,134 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,976,565 | 69,167 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,838,243 | 68,058 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $5,196,576 | 67,488 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $4,797,997 | 65,699 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $3,938,711 | 63,171 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $3,547,833 | 59,960 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $3,872,753 | 57,958 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $3,500,495 | 55,449 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $3,259,366 | 52,545 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $2,911,584 | 48,293 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $2,590,963 | 44,064 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $2,427,699 | 43,554 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||